A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis
Titel:
A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis
Auteur:
Brand, Stephen R. Degenhardt, Thorsten P. Person, Karen Sobel, Jack D. Nyirjesy, Paul Schotzinger, Robert J. Tavakkol, Amir